Tycho Peterson
Stock Analyst at Jefferies
(4.67)
# 190
Out of 4,711 analysts
127
Total ratings
65.91%
Success rate
18%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEO NeoGenomics | Initiates: Buy | $22 | $16.41 | +34.06% | 1 | Dec 10, 2024 | |
| DGX Quest Diagnostics | Assumes: Buy | $185 | $153.10 | +20.84% | 1 | Dec 10, 2024 | |
| QDEL QuidelOrtho | Initiates: Hold | $43 | $44.84 | -4.10% | 5 | Dec 10, 2024 | |
| HOLX Hologic | Initiates: Hold | $85 | $71.65 | +18.63% | 7 | Dec 10, 2024 | |
| QGEN Qiagen | Assumes: Buy | $42 → $54 | $44.67 | +20.89% | 5 | Dec 10, 2024 | |
| WAT Waters | Upgrades: Buy | $355 → $415 | $368.16 | +12.72% | 7 | Oct 8, 2024 | |
| TWST Twist Bioscience | Maintains: Underweight | $28 → $35 | $47.94 | -26.99% | 3 | Aug 5, 2024 | |
| RVTY Revvity | Maintains: Hold | $115 → $125 | $112.56 | +11.05% | 1 | Jul 29, 2024 | |
| TXG 10x Genomics | Upgrades: Buy | $24 | $14.04 | +70.94% | 7 | Jul 22, 2024 | |
| PACB Pacific Biosciences of California | Initiates: Buy | $4 | $1.97 | +103.05% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $1.76 | +70.45% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $161.88 | -12.28% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $31.67 | +1.04% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $136.02 | -15.45% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $13.36 | +49.70% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $524.05 | +24.03% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $1,230 → $1,250 | $1,230.74 | +1.56% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $13.24 | -32.02% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.90 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $2.31 | +419.48% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $10.50 | +471.43% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $3.26 | +605.52% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $900 | $19.55 | +4,503.58% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $185.77 | +109.94% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $150 | $134.51 | +11.52% | 7 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $2.49 | +823.69% | 1 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $3.64 | +394.51% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $524.43 | -61.86% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $18.70 | +28.34% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $18.70 | +140.64% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $160 | $1.16 | +13,693.10% | 4 | Sep 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $144.46 | -51.54% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $197.27 | -39.17% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.85 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $57.00 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $17.51 | +214.11% | 1 | Jul 19, 2016 |
NeoGenomics
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $16.41
Upside: +34.06%
Quest Diagnostics
Dec 10, 2024
Assumes: Buy
Price Target: $185
Current: $153.10
Upside: +20.84%
QuidelOrtho
Dec 10, 2024
Initiates: Hold
Price Target: $43
Current: $44.84
Upside: -4.10%
Hologic
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $71.65
Upside: +18.63%
Qiagen
Dec 10, 2024
Assumes: Buy
Price Target: $42 → $54
Current: $44.67
Upside: +20.89%
Waters
Oct 8, 2024
Upgrades: Buy
Price Target: $355 → $415
Current: $368.16
Upside: +12.72%
Twist Bioscience
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $47.94
Upside: -26.99%
Revvity
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $112.56
Upside: +11.05%
10x Genomics
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $14.04
Upside: +70.94%
Pacific Biosciences of California
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.97
Upside: +103.05%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $1.76
Upside: +70.45%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $161.88
Upside: -12.28%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $31.67
Upside: +1.04%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $136.02
Upside: -15.45%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $13.36
Upside: +49.70%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $524.05
Upside: +24.03%
Jun 3, 2024
Assumes: Underperform
Price Target: $1,230 → $1,250
Current: $1,230.74
Upside: +1.56%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $13.24
Upside: -32.02%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.90
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $2.31
Upside: +419.48%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $10.50
Upside: +471.43%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $3.26
Upside: +605.52%
Jun 21, 2021
Initiates: Overweight
Price Target: $900
Current: $19.55
Upside: +4,503.58%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $185.77
Upside: +109.94%
May 26, 2021
Maintains: Overweight
Price Target: $140 → $150
Current: $134.51
Upside: +11.52%
May 11, 2021
Initiates: Overweight
Price Target: $23
Current: $2.49
Upside: +823.69%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $3.64
Upside: +394.51%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $524.43
Upside: -61.86%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $18.70
Upside: +28.34%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $18.70
Upside: +140.64%
Sep 27, 2019
Downgrades: Underweight
Price Target: $160
Current: $1.16
Upside: +13,693.10%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $144.46
Upside: -51.54%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $197.27
Upside: -39.17%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $1.85
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $57.00
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $17.51
Upside: +214.11%